Navigation Links
Hepatitis C treatment less effective in urban minority patients
Date:3/25/2010

A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

According to the CDC's Office of Minority Health & Health Disparities (OMHD), minorities experience a disproportionate burden of preventable disease, death, and disability compared with non-minorities. Groups currently experiencing poorer health status are expected to grow as a proportion of the total U.S. population. African Americans have higher rates of HCV and hepatitis B (HBV) infection than whites or Hispanics, while hepatitis A (HAV) rates are higher among Hispanics than among non-Hispanics. Current information about the biologic and genetic characteristics of minority populations does not explain the health disparities experienced by these groups compared with the white, non-Hispanic population in the U.S. These disparities are believed to be the result of the complex interaction among genetic variations, environmental factors, and specific health behaviors.

A study conducted at the Albert Einstein College of Medicine supports the disparity in drug efficacy among various minority populations. Researchers analyzed combination pegylated interferon and ribavirin, which has proved an effective treatment regimen for HCV in clinical trials, but doesn't yield the same success rates in daily clinical practice, particularly with minority patients. Study leader Dr. John F. Reinus explains, "Industry-sponsored trials are conducted with the advantage of extraordinary resources to ensure that all aspects of therapy with a study drug are accurately controlled, observed and documented."

Researchers
'/>"/>

Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Bipartisan Capitol Hill Media Event: Health Experts, Lawmakers to Urge Federal Government to Fix the Funding Failure for Chronic Viral Hepatitis
2. Vaccination, Prevention Is Beating Back Hepatitis
3. 1 in 5 At-Risk U.S. Babies Doesnt Get Hepatitis B Vaccine
4. Groundbreaking research to find vaccine for hepatitis C
5. New screening system for hepatitis C
6. NVHR: Administrations 2011 Budget Proposal Shortchanges Five Million Americans Afflicted with Chronic Viral Hepatitis
7. NVHR Issues Challenge to Administration, Congress: Dont Leave 5 Million Americans Afflicted with Chronic Viral Hepatitis Out in the Cold with Budget Freeze
8. New Treatment Eyed for Hepatitis C
9. Treatment for chronic hepatitis C: A phase II study
10. IOM report recommends steps to tackle hepatitis B and C
11. Key to Hepatitis C May Be Two Cellular Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Provo, Utah (PRWEB) , ... June 30, 2015 ... ... and corporate training, has released a new website intended for executives and administrators ... significantly enhance user experience, and the final product is a result of comprehensive ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... desire to educate readers and potential patients about a variety of plastic surgery ... cosmetic dentistry and more. , It has been the main focus of Cosmetic ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... to its multidisciplinary group of physicians and specialists. Dr. Cook is experienced with ... healthcare in hopes of achieving outstanding medical outcomes. , “We are very excited ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... Martin Del Campo is their newest FAA-certified medical examiner in the city of ... for all fledging pilots seeking to obtain their physical aviation certificates. Pilots hoping ...
(Date:6/29/2015)... Wisconsin (PRWEB) , ... June 29, 2015 , ... ... with the news that the European Medicines Agency (EMA) has granted accelerated approval ... “Melanoma remains a global public health threat and the approval of nivolumab for ...
Breaking Medicine News(10 mins):Health News:Career Step Launches New Website to Better Meet Needs of Partners, Clients and Others Searching for Corporate Training Solutions 2Health News:Board of Advisors Now Coming to Cosmetic Town 2Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 2Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 3Health News:Healthpointe Now Offering FAA Physical Exams in San Bernardino County 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3
... overweight and obese people getting? More than many ... Case Western Reserve University,s Frances Payne Bolton School of ... Journal of the American Academy of Nurse Practitioners ... individuals." Deborah Walton Smith, who is now a ...
... failure who repress their emotions, especially anger, are more ... depression associated with knowledge about their disease, according to ... study influenced how depressed or anxious they felt. The ... more likely they were to have symptoms of depression ...
... Not a single person identified with autism or asperger,s ... they had the condition, research led by the University ... Professor of Psychiatry at the University of Leicester, the ... males, those without higher educational qualifications, and those living ...
... Children,s health problems caused by air pollution, exposure to toxic ... billion in 2008, a new study finds. That was ... compared with 2.8 percent in 1997, said researchers from the ... the cost of childhood cancer and chronic conditions such as ...
... studies have shown that a 64-detector CT angiography ... image but considerably reduced patient radiation dose when ... being presented at the 2011 American Roentgen Ray ... in the Department of Radiology at the University ...
... HealthDay Reporter , TUESDAY, May 3 (HealthDay News) -- The ... more than 12 percent between 2001 and 2009, U.S. health ... people, according to the U.S. Centers for Disease Control and ... million Americans have asthma "and that number, unfortunately, is rising," ...
Cached Medicine News:Health News:Making the move to exercise for overweight and obese people 2Health News:More knowledge not always helpful for women dealing with heart disease 2Health News:More knowledge not always helpful for women dealing with heart disease 3Health News:More knowledge not always helpful for women dealing with heart disease 4Health News:'Most adults with autism go undiagnosed' -- new findings 2Health News:'Most adults with autism go undiagnosed' -- new findings 3Health News:Treating Kids for Environmental Ills Costs U.S. $76B a Year 2Health News:Low-dose chest CT effective in reducing radiation for evaluation of cardiothoracic surgery patients 2Health News:Number of Americans With Asthma Keeps Rising 2Health News:Number of Americans With Asthma Keeps Rising 3
(Date:6/29/2015)... MELVILLE, N.Y. , June 29, 2015 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, announced today that it has ... by the Association of Hispanic Healthcare Executives (AHHE), ... and policies to increase the presence of Hispanic ...
(Date:6/29/2015)... 29, 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... to the Russell 2000® Small Cap, Russell 3000®, and ... at the close of trading on June 26, 2015 ... of U.S. and global indexes. Sorrento is already a ... About the Russell Indexes. Russell indexes ...
(Date:6/29/2015)... SAN FRANCISCO , June 29, 2015 ... novel blood-draw technology has received CE Mark (Conformite ... from the European Union. This regulatory milestone further ... to one of the most common procedures in ... Velano Vascular,s proprietary device reduces the need ...
Breaking Medicine Technology:Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 2Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 3Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 4Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 5Henry Schein Selected As Corporation of the Year By The Association of Hispanic Healthcare Executives 6Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 2Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes 3Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2
... Inc. (the "Company") (Nasdaq: CMED ), a leading China-based ... the fourth fiscal quarter ("4Q FY2010") and the full fiscal year ... Highlight sFor   the   ...   31,   2010March   31, ...
... Medical, Inc. will sell its BioTREK technology platform, which has ... the firm Finn, Warnke & Gayton, LLP to be liquidated ... bid sale of June 10, 2011. BioTREK ... to create a family of percutaneous devices for repair or ...
Cached Medicine Technology:China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 2China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 3China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 4China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 5China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 6China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 7China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 8China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 9China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 10China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 11China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 12China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 13China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 14China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 15China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 16China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 17China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 18China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 19China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 20China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 21China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 22China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 23China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 24China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results 25NMT Medical, Inc. to Sell BioTREK Technology Platform at Its Sealed Bid Sale on Friday, June 10, 2011 at Twelve O'Clock Noon 2
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Molt periosteal elevator #9, 18.5 cm, 7-1/4"....
Obwegeser periosteal elevator, angled, 9 mm, 20 cm, 8"....
... Deformity System unites the clinical experience ... and Isola with revolutionary technology developed ... unsurpassed versatility, simplicity and security. Frontier ... versatility for treating a deformity from ...
Medicine Products: